Q-line Biotech Ltd Quarterly Result
Q-Line Biotech Ltd
NSE: Q-LineBiotech
Net Profit - Last Quarter
null Quarterly Results Key Highlights
- The revenue of Q-Line Biotech Ltd for the Mar '26 is ₹ 110.94 crore as compare to the Dec '25 revenue of ₹ 90.03 crore.
- This represent the growth of 23.23% The ebitda of Q-Line Biotech Ltd for the Mar '26 is ₹ 33.57 crore as compare to the Dec '25 ebitda of ₹ 30.54 crore.
- This represent the growth of 9.92% The net profit of Q-Line Biotech Ltd for the Mar '26 is ₹ 17.03 crore as compare to the Dec '25 net profit of ₹ 17.38 crore.
- This represent the decline of -2.01%.
null Quarterly Results Analysis
Market Price of Q-Line Biotech Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 28 Jul 2026 | 496.55 |
| 27 Jul 2026 | 500.3 |
| 24 Jul 2026 | 505.75 |
| 23 Jul 2026 | 498.9 |
| 22 Jul 2026 | 510.25 |
| 21 Jul 2026 | 511.4 |
| 20 Jul 2026 | 531.4 |
| 17 Jul 2026 | 537.85 |
| 16 Jul 2026 | 555.5 |
| 15 Jul 2026 | 552.4 |
Historical Revenue of Q-Line Biotech Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Q-Line Biotech Ltd
Historical EBITDA of Q-Line Biotech Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Q-Line Biotech Ltd
Historical Net Profit of Q-Line Biotech Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Q-Line Biotech Ltd
Q-Line Biotech Ltd News Hub
NSE SME Q-Line Biotech lands on Dalal Street with a strong pulse
The scrip was listed at Rs 452, a 31.78% premium to the initial public offer (IPO) price. The stock
Read more
29 May 26
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
About Q-Line Biotech Ltd
- Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
- Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
- Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.
FAQs for Quarterly Results of null
What key financial metrics are included in Q-Line Biotech Ltd's quarterly results?
When does Q-Line Biotech Ltd announce its quarterly results?
How does Q-Line Biotech Ltd's quarterly performance impact its stock price?
What is the impact of Q-Line Biotech Ltd's quarterly results on dividends?
Are there any special announcements usually made during Q-Line Biotech Ltd's quarterly results?
